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Sodium-chloride-induced protection in nephrotoxic acute renal
failure: Independence from renin. It has been shown that the se-
verity of experimentally induced acute renal failure (ARF) is in-
versely related to dietary sodium chloride intake, and the effects
have been attributed to the concurrent changes in renal renin. In
the current study, renal renin of rats was increased by chronic
sodium deprivation and decreased by chronic sodium loading
and DOCA administration. In two nephrotoxic models (mercuric
chloride, uranyl nitrate), giving previously sodium-deprived rats
1% sodium chloride to drink for 48 hours prior to ARF induction
greatly attenuated the severity without any reduction in their
high renal renin. Conversely, giving previously sodium-loaded
rats tap water to drink for 4 to 5 days prior to AFR induction
greatly enhanced the severity without any increase in their sub-
normal renal renin. Therefore, the changes in severity of ARF
resulting from changes in dietary sodium are not mediated by
changes in renal renin, Significant inverse correlations were
found between mean peak BUN values during the follow-up peri-
od (5 to 7 days) and the 24-hour urinary sodium excretions prior
to ARF induction in both models, suggesting that sodium intake
and/or excretion at the time of induction is a good predictor of
the severity. The effects of sodium chloride in both models were
predominantly expressed during the maintenance phase, and
consisted of attenuation of the severity (both models) and has-
tening of the recovery (mercuric chloride model). Possible mech-
anisms by which dietary sodium produced its effects, independ-
ently of its effects on the renin-angiotensin system, are dis-
cussed.
Effet protecteur de chlorure de sodium vis-à-vis de l'insufllsance
rénale aiguë néphrotoxique: Indépendance de Ia refine. II a été
montré que la sévérité de l'insuffisance rénale aigue ex-
périmentale (ARF) est en proportion inverse de Ia charge alimen-
taire en le chlorure de sodium, et cet effet a été attribué aux
modifications de la rénine rénale. Dans ce travail la rénine rénale
a été, chez des rats, augmentée par une déplétion chronique en
sodium et diminuée par une charge chronique en chlorure de
sodium et de la DOCA. Dans deux modéles de néphrotoxicité
(chlorure mercurique et nitrate d'uranyle) le fait de donner aux
animaux préalablement déplétés en sodium du chlorure de sodi-
um 1% comme boisson pendant 48 heures avant l'induction de
l'ARF a atténué Ia sévérité de celle-ci sans modifier la concen-
tration élevée de rénine rénale. A l'inverse, le fait de donner a
des rats préalablement charges en sel de l'eau du robinet comme
boisson pendant 4 ou 5 jours avant l'induction de l'ARF aug-
mente considérablement Ia sévérité de celle-ci sans élever la
concentration, inférieure ala normale, de rénine rénale. Ainsi les
modifications de la sévérité de l'ARF consécutives aux modifica-
tions de l'apport alimentaire de sodium n'ont pas Ia rénine rénale
comme médiateur. Des relations inverses significatives ont été
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observées entre l'azote sanguin non protéique pendant Ia pé-
node d'observation (5 a 7 jours) et Ia natriurèse de 24 heures
avant l'induction de l'ARF dans les deux modèles, ce qui sug-
gère que l'apport alimentaire et/ou l'excrétion de sodium au
moment de l'induction d l'ARF sont un bon élément de pré-
vision de Ia sévérité. Les effets de chlorure de sodium dans ces
modèles sont surtout exprimés au cours de l'évolution et con-
sistent en une diminution de Ia sévérité, dans les deux modèles,
et une recuperation plus précoce, dans le modèle oO le chlorure
mercurique est utilisé. Les mécanismes par lesquels le sodium
alimentaire produit ces effets, indépendamment des effets sur Ic
système rénine-angiotensine, sont discutés.
It has been shown that if rats are given 1% so-
dium chloride or 2% potassium chloride to drink for
several weeks, rather than tap water, they are pro-
tected against acute renal failure (ARF) induced by
the administration of glycerol, mercuric chloride,
dichromate, or uranyl nitrate [1—6]. This protective
effect of chronic salt loading has been attributed to
depletion of renal cortical renin content (RCRC) [I,
4—6]. Moreover, chronic sodium restriction, which
increases RCRC [7], enhances the severity of glyce-
rol-induced ARF in rats [8]. Although no cause-
and-effect relationship between RCRC and severity
of ARF has been established, these observations
are consistent with the hypothesis that RCRC is
directly related, in a nearly proportional manner, to
the severity of experimentally-induced ARF [4, 6].
Thiel et a! [9] have shown that protection in the
mercuric chloride model can be achieved without
suppression of renal renin. We have shown that
protection in the glycerol model antedates any de-
tectable suppression of renal renin during the
course of salt loading [10]. Although RCRC was not
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detectably suppressed in either of these studies, it is
conceivable that renin activity at a critical intra-
renal site was decreased, mediating the protective
effects. Thus, a clear dissociation of the effects of
salt loading on the renin-angiotensin system and on
the severity of ARF has not been demonstrated.
The present study was designed to examine the
possible independent effects of changes in sodium
chloride intake on RCRC and on the severity of
mercuric-chloride- and uranyl-nitrate-induced ARF
in rats.
Methods
Female Sprague-Dawley rats weighing between
175 and 300 g were used in this study. The experi-
mental protocol is outlined in Fig. 1. Group-A rats
(normal RCRC) were given tap water and Purina
Lab Chow. In groups B and C (low RCRC), 1% so-
dium chloride was substituted for tap water, and
each rat received 10 mg of DOCA/kg body wt, s.c.,
four to five times per week for 5 to 6 weeks. Four to
five days before the experiments, the DOCA injec-
tions were stopped, and tap water was substituted
for sodium chloride in group C. In groups D, E, and
F (high RCRC), a low-sodium diet ("Rat Modi-
fied," Nutritional Biochemicals, Cleveland, Ohio)
was given for 5 to 6 weeks. Four to five days before
the experiments, group E was switched to the nor-
mal chow. It was expected that groups C and E
would be similar with respect to salt balance, but
different with respect to RCRC, at the time of in-
duction of ARF. To determine if protection could
be achieved despite high RCRC, we gave group F
1% sodium chloride to drink for 48 hours before
ARF induction. The numbers of animals in each
group and subgroup can be found in Tables 1 and 2.
All animals were kept in metabolic cages, and
fluid intake and urine output were monitored for the
24 hours before the experiments. Urine was ana-
lyzed for sodium, potassium, and chloride as de-
scribed below. Then, random animals from groups
A to F were sacrificed for determination of RCRC
and plasma renin concentration (PRC). Rats were
decapitated, and blood was collected within 10 to 15
seconds in chilled, heparinized tubes. These were
centrifuged at 4° C, and the plasma was frozen until
analysis. Kidneys were removed, put in iced 150
m sodium chloride, and stored frozen until analy-
sis.
Tail-vein blood samples were obtained from the
rest of the animals in groups A to F for baseline
BUN determinations. Then ARF was induced by
subcutaneous injection of either mercuric chloride
(4.7 mg/kg body wt) or uranyl nitrate (5 mg/kg body
wt). To follow the course of ARF, we determined
BUN concentrations (tail-vein blood sample) on
days 1, 2, 3, 5, and 7 after the injections. Dietary
regimens during this time were the same as those in
force at the time of ARF induction. At the end of
the follow-up period, enough blood was collected
from some of the sacrificed rats for simultaneous
determinations of BUN and serum creatinine con-
centrations.
To determine the PRC response to mercuric chlo-
ride, we sacrificed additional animals of groups A to
F by decapitation 6 hours after injection. In these
Experimental protocol
Regular chow +
DOCA SQ +
1% NaCI 5 to 6 wks
r I
Continued Switched to
DOCA+ tapH2O±
1% NaCl stop DOCA
4 to 5 days
Group B Group C
Low-Na diet +
tap H20 5 to 6 wks
Continued Switched to
on ow-Na regular diet
diet +tap H20
4 to 5 days
Group D Group F
Low Na
diet +
1% NaCl
2 days
Group F
All groups were randomly subdivided into 4 subgroups:
1. Sacrificed for basal RCFtC and PRC measurements
2. Sacrificed 6 hrs after HgCI2 4.7 mg/kg SQ for PRC
3. Followed for ARF after SQ HgCI2 4.7 mg/kg
4. Followed for ARF after SQ uranyl nitrate 5 mg/kg
Fig. 1. Experimental protocol. Renal cortical renin content (RCRC) of female Sprague Dawley rats varied between low (groups B and C)
and high (groups D to F). Short-term changes in sodium intake were imposed as indicated. PRC is plasma renin concentration; ARF is
acute renal failure.
Female Sprague Dawley rats
(body wt., 175 to 300 g)
Regular
rat chow
(Purina) +
tap H2Q
Group A
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Table 1. Baseline BUN and 24-hour excretion data, groups A to Ca
BUN
mgIJOO ml
V
m1124 hrIlOO g body WI
UNaV U1V UKV
pEq/24 hrIIOO g body wt
Group A
RCRC(9) 15 1 7 1 274 59 270 60 532 119
PRC(8) — 4 1 227 41 251 50 432 113
HgC12(13) 14 1 6 1 334 41 433 69 721 82
UN(1l) 15 1 4.0 0.4 233 40 281 46 474 71
Group B
RCRC(l1) 13 1 26 3 5191 562 5121 562 825 95
PRC (9) 28 2 5593 422 5469 440 455 104
HgC12(9) 19 3 28 3 5815 460 5973 499 899 196
UN (12) 18 1 27 2 5903 380 5228 382 393 57
Group C
RCRC(1l) 14 2 8 1 466 74 520 90 842 140
PRC(8) — 6 1 494 57 555 75 950 118
HgC12(10) 14 1 7 1 496 70 565 87 828 105
UN(10) 15 2 7 1 539 80 574 112 884 153
a Valuesare means SEM. Number of animals per subgroup is in parentheses. Refer to text or Fig. I for treatment of groups A, B, and
C. Subgroups are: RCRC, rats sacrificed for determination of renal cortical renin content; PRC, rats sacrificed 6 hours after injection of
mercuric chloride for determination of plasma renin; HgCl2 and UN, rats injected with mercuric chloride and uranyl nitrate, and followed
for up to 7 days to determine the course of acute renal failure.
Table 2. Baseline BUN and 24-hour excretion data, groups D to F
BUN
mgIJOOml
V
m1124hrIlOO g body Wi
UNaV UniV UKV
Eq/24 hr/IO0 g body WI
GroupD
RCRC(l0) 14 1 6 1 29 10 269 74 511 106
PRC(6) — 4 1 34 7 376 133 445 122
HgC12(l0) 15 1 4.0 0.5 39 11 354 56 536 76
UN(ll) 15 1 4 1 31 14 443 75 648 102
Group E
RCRC(8) 14 1 6.0 0.4 404 55 447 72 672 119
PRC(9) — 6 1 332 54 351 63 592 91
HgCI2(12) 15 1 6 1 375 53 461 61 707 94
U.N. (10) 15 1 5 1 356 41 451 56 757 83
Group F
RCRC(9) 14 1 10 1 2501 278 2714 335 906 160
PRC(7) — 11 1 2382 215 2601 289 783 128
HgCI2(10) 15 1 9 1 1748 105 1813 144 573 114
UN(l5) 16 1 15 1 3110 295 3203 312 973 92
a Valuesare means SEM. Number of animals per subgroup is in parentheses. Refer to text or to Fig. 1 for treatment of groups D, E,
and F. Subgroups are: RCRC, rats sacrificed for determination of renal cortical renin content; PRC, rats sacrificed 6 hours after injection
of mercuric chloride for determination of plasma renin; HgCl2 and UN, injected with mercuric chloride and uranyl nitrate and followed
for up to 7 days to determine the course of acute renal failure.
animals, no blood was drawn for baseline BUN de-
terminations.
Sodium and potassium concentrations were mea-
sured by flame photometry, with internal lithium
standardization. Urinary chloride was measured by
titration, with a direct-reading Corning chloride me-
ter. BUN was measured with a General Diagnostic
BUN-Strate Kit, based on a method described by
Weatherburn [11]. Serum creatinine concentration
was measured with a colonmetric method [12].
Methods for RCRC and PRC were described in re-
cent publications of this laboratory [13, 14]. Briefly,
renin-containing samples (homogenized renal cor-
tex, plasma) were added to rat renin substrate [15]
and incubated at 37° C in the presence of inhibitors
of converting enzyme and angiotensinases [16]. In-
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cubations were stopped by cooling to 4° C, and the
generated angiotensin I was measured by radioim-
munoassay. RCRC was expressed in nanograms of
angiotensin I per hour of incubation per milligram
wet wt of renal cortex (ng Al/hr/mg), and PRC in
nanograms of angiotensin I per hour of incubation
per milliliter of plasma (ng Al/hr/mi).
Student's t test was used to assess the statistical
significance of observed differences. Because of
multiple groups and subgroups of different num-
bers, only P values less than 0.01 were considered
significant in some comparisons [17].
Results
Baseline BUN concentration, urine flow, and
electrolyte excretion of all rats for the 24 hours pre-
ceding the experiments are summarized in Tables 1
and 2. Within all groups, the subgroups (for ex-
ample, rats sacrificed for baseline RCRC determina-
tion) were comparable. Animals drinking tap water
and eating the normal chow at the time of the exper-
iments (groups A, C, and E) were excreting similar
amounts of water and electrolytes despite the pre-
vious dietary manipulations of groups C and E. So-
dium excretion of rats on the low-sodium diet
(group D) was an order of magnitude less, and that
of rats on the high-sodium diet (group B) an order of
magnitude greater than control. Short-term sodium
loading in previously sodium-deprived rats (group
F) resulted in an intermediate enhancement of
UNaV, from four to six times the control value.
In 31 rats injected with mercuric chloride, BUN
and serum creatinine concentrations were simulta-
neously determined at the time of sacrifice, 5 to 7
days later. BUN concentration ranged from 15 to
400 mg/lOO ml; and serum creatinine, from < 1.0 to
18 mg/l00 ml. Rats from all three dietary regimens
were included: group D, N = 7 (low sodium);
groups A, C, and E, N = 14 (normal sodium);
groups B and F, N = 10 (high sodium). The correla-
tion coefficient between BUN and serum creatinine
concentrations was 0.97, P < 0.001. Similarly, the
correlation coefficient between BUN and serum
creatinine concentrations was 0.93, P < 0.001, in 35
rats (all three dietary groups) sacrificed 5 to 7 days
after uranyl nitrate injection. Thus, changes in ei-
ther serum creatinine or in BUN are equally good
reflections of changes in GFR.
Means of baseline RCRC and PRC, of PRC 6
hours after injection, and of peak BUN of the vari-
ous groups injected with mercuric chloride are
shown in Fig. 2. As assessed by peak BUN concen-
tration, severity of ARF was identical in groups C
and E, neither of which was significantly different
from group A. In comparison, severity of ARF was
markedly reduced in groups B and F, and mean
peak BUN concentrations of these two groups were
not significantly different from each other. These
A B C D F F
C)
C-)
I;
1500
500
30
20
10
40
30
20
10
300
150
E
(13) (9) (10) (10) 12) (10)
Fig. 2. Effects of short-term and long-term changes in sodium intake on renal cortical renin content (RCRC), on plasma renin concentra-
lion (PRC) before and 6 hours after induction of ARF with mercuric chloride, and on severity of resulting ARF (as assessed by mean
peak BUN during the follow-up period). Number of rats is given in parentheses. Asterisks denote values significantly different from
control group A (P < 0.01).
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RCRC. Exactly the opposite conclusion could be
reached, however, if only groups A, C, and F are
considered; namely, high RCRC is protective
against, whereas low RCRC enhances the severity
of, ARF induced by mercuric chloride.
In Fig. 4, mean peak BUN concentrations of the
six groups of uranyl nitrate—injected rats are plotted
against corresponding mean RCRC's. Comparison
of mean BUN concentrations of groups A, B, and F
suggests that both short-term and long-term sodium
chloride loading were protective against ARF in this
oo nephrotoxic model, but long-term loading was more
protective, as mean BUN of group B was signifi-
cantly less than that of group F. Mean peak BUN
concentrations of groups A and D were not signifi-
cantly different from each other, suggesting that
long-term dietary sodium restriction does not en-
hance the severity of ARF induced by uranyl ni-
trate. This differed from the result obtained in mer-
curic-chloride-injected animals (Figs. 2 and 3). Be-
cause mean peak BUN of group-A uranyl-nitrate-
injected rats was considerably higher, however,
than group—A mercuric-chloride-injected rats (282
28 vs. 180 36 mg!l00 ml, P < 0.05), this may
mean only that uranyl nitrate at the dose we used
causes maximal impairment of renal function even
in rats on a normal sodium diet. In any case, RCRC
was clearly dissociated from the severity of ARF
induced by uranyl nitrate injection.
As suggested above, severity of ARF in the mer-
curic-chloride-injected rats appeared to be in-
versely related to dietary sodium at the time of in-
jection. This suggestion is strengthened by data pre-
sented in Fig. 5. Mean peak BUN concentrations of
groups A to F rats are plotted against corresponding
mean 24-hour urinary sodium excretions prior to
mercuric chloride injection (sodium intake itself
was not monitored). A highly significant inverse
correlation was observed (r = 0.94, P < 0.01). A
somewhat lower inverse correlation (r = 0.91, P <
0.05) was found in the uranyl nitrate model of ARF
(Fig. 6).
To study the course of ARF and how it was af-
fected by dietary sodium, we combined for sim-
plification groups A, C, and E (normal intake at the
time of injection) and we combined groups B and F
(1% sodium chloride rather than tap water at the
time of injection). The course of ARF for the three
dietary groups injected with mercuric chloride is
shown in Fig. 7. In general, mean BUN concentra-
tions at all times measured were inversely related to
dietary sodium. Furthermore, the time at which
BUN began to decline was inversely related to diet-
300
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Na intake during ARE:
Low Na (group D)
Normal Na (groups A, C, E)
o High Na (groups B, F( TI
TA
r0.122 _4_,
P>0.1 'B
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a,
E
-a'
0
100 1000
RCRG, ng Al/mg wt wt
Fig. 3. Dissociation of renal cortical renin content (RCRC) from
the severity of ARF induced by mercuric chloride, as assessed by
mean peak BUNfollowing induction.
observations suggest that the severity of ARF is
related to sodium intake at the time of induction
of ARF, as groups A, C, and E had normal rat chow
and tap water whereas groups B and F had the same
rat chow supplemented with sodium chloride to
drink.
No pattern was seen between severity of ARF
and either baseline PRC or the PRC response to
mercuric chloride injection (Fig. 2). For example,
both baseline PRC and PRC response were sup-
pressed comparably below normal (group A) in
groups B and C, but peak BUN concentration was
suppressed only in group B. Thus, neither PRC be-
fore the nephrotoxic insult nor the change in PRC
during the first few hours after the insult appear to
play a role in the severity of ARF that develops.
As can also be seen in Fig. 2, means of RCRC in
groups B and C were not significantly different from
each other, but both were lower than mean RCRC
of group A. Groups D, E, and F were not signifi-
cantly different from each other, but all had signifi-
cantly higher RCRC than did Group A. Thus, short-
term changes in dietary sodium (for example, 1%
sodium chloride rather than tap water for 48 hours,
group F; tap water rather than 1% sodium chloride
for 4 to 5 days, group C) superimposed on the diet-
ary manipulations of 5 to 6 weeks' duration were
not sufficient to modify RCRC, but were sufficient
to markedly alter the severity of ARF. This can be
seen best in Fig. 3, in which mean peak BUN con-
centrations are plotted against mean RCRC's of the
various groups. If only groups A, B, and D, are con-
sidered, the observations confirm those of other in-
vestigators [4, 6, 181, that severity of ARF is direct-
ly related, in a nearly proportional manner, to
DE
Na intake during ARF:
o Low Na (group D)
Normal Na (groups A, C, E(
o High Na (groups B, F(
Br = 0.416
P> 0.1
= 0.91
P<0.05
.1
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UN,V before uranyl nitrate, rnEq/24 hr/bOg body wt
Fig. 6. Inverse correlation between severity of ARF (mean peak
BUN) and mean U0V during the 24 hours prior to uranyl nitrate
injection. Groups A to F are defined in Fig. 5.
Na intake during ARF:
300 0 Low Na (group D(
Normal Na (groups A, C, E(
0 High Na (groups B, F(
200 r'I
100 /
1 2 3 5 7
Time after HgCI2, 4.7 mg SQ. days
Fig. 7. Pattern of ARF, as assessed by B UN following injection
with mercuric chloride. Low, normal, and high sodium refer to
dietary sodium before and after injection.
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Fig. 4. Dissociation of renal cortical renin content (RCRC) from
the severity of ARF induced by uranyl nitrate injection, as as-
sessed by mean peak BUN following induction.
ary sodium. Thus, high sodium both reduces seven-
ty and hastens recovery, whereas low sodium en-
hances severity and delays recovery, in the mercur-
ic chloride model of ARF. The patterns for the same
three dietary regimens in the uranyl nitrate model
are shown in Fig. 8. Comparison of Figs. 7 and 8
reveals some interesting differences in these two
nephrotoxic models. BUN concentration increased
more slowly, but to much higher final values, in the
uranyl nitrate model. Moreover, in this model, no
definite recovery was noticed by day 7. Although
mean BUN concentrations of both normal and low
sodium groups declined between days 5 and 7, this
could be attributed to very high mortality rates, the
values at 7 days representing the BUN concentra-
tions of the less severely affected animals. Ex-
300
C
200I
1
100
E
50
r = 0.942
P = <0.01
Na intake during ARF:
o Low Na (group D(
s Normal Na (groups A, C, E)
o High Na (groups B, F(
fF
10.1 1
UN,V before HgCI2,mEq/24hr/lOOgbody wt
Fig. 5. inverse correlation between severity of ARF (mean peak
BUN) and mean UNSV during the 24 hours prior to mercuric
chloride injection. Group D was on a low-, groups A, C, and E
on a normal-, and groups B and F on a high-sodium diet at the
time of injection and thereafter. Correlation coefficient and P val-
ue were from linear least-squares regression analysis.
1 2 3 5 7
Time after uranyl nitrate, 5 mg/kg SO, days
Fig. 8. Pattern of development of ARF, as assessed by BUN,
following injection of uranyl nitrate. Low, normal, and high so-
dium refer to dietary sodium before and after induction of ARF.
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cluding the sacrificed rats, mortality rates for ani-
mals on low-, normal-, and high-sodium intakes
were 7/10, 11/35, and 2/19 for mercuric chloride-in-
jected rats, and 8/11, 15/31, and 2/27 for the uranyl-
nitrate-injected rats. Finally, in contrast to the mer-
curic chloride model, differences between the three
dietary groups were minimal for the first 2 days.
Discussion
The renin-angiotensin system (RAS) has been
postulated to play a major pathogenic role in both
the initiation and the maintenance phases of experi-
mentally induced ARF [6, 18—25]. Indeed, factors
known to enhance the activity of the RAS, such as
fluid deprivation and/or low sodium intake, enhance
the severity of myoglobinuric ARF [8, 26], and sup-
pression of the RAS achieved by long-term sodium
chloride or potassium chloride loading, protects
against ARF induced by the administration of glyce-
rol, dichromate, mercuric chloride, or uranyl nitrate
[1-6]. Suppression of plasma renin, however, does
not attenuate the severity of experimentally in-
duced ARF in rats, as shown in this study (groups A
vs. C) and in others [27]. Neither does any one of a
variety of manipulations, all of which block the ef-
fects of circulating renin: renin immunization [18];
active and passive angiotensin II immunization [28];
administration of SQ 20,881, an inhibitor of con-
version of angiotensin I to angiotensin II [29, 30];
administration of P113, a competitive inhibitor of
angiotensin II [29, 30]. Taken together, these obser-
vations exclude PRC itself as a pathogenic factor,
but they do not exclude intrarenal renin, via local
production and action of some species of angioten-
sin (I, II, or III [31]) at sites inaccessible to anti-
bodies and pharmacologic inhibitors. Because this
site might be intracellular [31, 32], and there are no
techniques available for directly measuring activity
of the RAS at this site, RCRC is currently used as
an index. Despite the lack of a proven correlation
between RCRC and activity of the RAS at the criti-
cal site, only RCRC determinations are available to
support the hypothesis that intrarenal renin activity
is directly related to the severity of experimentally
induced ARF [4, 6, 18].
This study clearly demonstrates that up to 20-fold
changes in RCRC have little effect in influencing the
severity of ARF, as judged by peak BUN values, in
two nephrotoxic models. In fact, this study shows
for the first time that rats with high RCRC (four
times control value) can be protected against ARF
induced with mercuric chloride or uranyl nitrate, by
short-term increases in sodium intake and/or excre-
tion. Moreover, RCRC depletion itself failed to pro-
tect against ARF, in the absence of increased so-
dium intake and/or excretion (groups A vs. C). This
observation is strengthened by our previous reports
that the two kidneys of Goldblatt rats, despite large
differences in RCRC, exhibit equal degrees of ARF
in response to injections of glycerol [13] or mercuric
chloride [33]. The fallacy of assuming a casual rela-
tionship between changes in RCRC and severity of
ARF is readily apparent in Fig. 3, enabling one to
argue either that increases in RCRC attenuate or,
conversely, that increases in RCRC enhance the se-
verity of ARF induced by mercuric chloride, de-
pending upon the groups considered.
When the basal PRC, the PRC response to mer-
curic chloride, and the RCRC are considered to-
gether, some interesting features are noted. Though
good correlations have been observed between re-
nm release and RCRC [34-36], Fray [37] has sug-
gested that renin release is a function of both RCRC
and the sodium intake at the time of stimulated re-
lease. If it can be assumed that PRC reflects renin
release, the fact that both PRC and the PRC response
to mercuric chloride were suppressed in groups B
and C is not surprising in view of their markedly sup-
pressed RCRC. On the other hand, the sodium-in-
take factor might be the explanation for differences
in PRC and PRC response to mercuric chloride in
groups D to F, despite very similar RCRC. With re-
spect to ARF, though the severity does seem to par-
allel the PRC response to mercuric chloride in
groups D to F (Fig. 2), it is clear from examining
groups B and C that severity is completely inde-
pendent of either PRC or the PRC response to mer-
curic chloride.
On the other hand, sodium chloride intake and/or
excretion is a good predictor of the severity of ARF
in both these nephrotoxic models, regardless of the
status of the RAS. Thus, a clear separation of the
independent effects of sodium chloride on RCRC
and on the severity of ARF has been demonstrated
in two nephrotoxic models.
The precise reasons for the differences between
the two nephrotoxic models, revealed by comparing
Figs. 7 and 8, are not clear. In the uranyl nitrate
model, BUN increased more slowly, but eventually
to much higher levels, and there was no clear-cut
recovery during the observation period. Previous
work has shown that increased permeability of the
tubular basement membrane, with associated back-
leak of glomerular filtrate, is a major component of
the uranyl nitrate model, at least during the mainte-
nance phase [38—40]. In contrast, an element of
tubular obstruction is present in the low-dose mer-
curic chloride model [41]. These differences may be
responsible for the different patterns of develop-
ment of ARF in the two models. There were also
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differences between the two models of ARF with
respect to the influence of sodium diet. In Fig. 7, the
mercuric chloride model, there is a clear separation
of groups on low-, normal-, and high-sodium diets.
Not only was the severity of ARF ameliorated in
the high-sodium group, there was a striking inverse
relationship between sodium diet and the time at
which recovery began. This suggests that one of the
important consequences of increased sodium intake
is to hasten recovery and shorten the maintenance
phase in the mercuric chloride model. The same
may be true in the glycerol model, as Thiel et al
[42] found no difference between control rats and
rats drinking 1% sodium chloride during the first 4
hours following injection. The latter rats were char-
acterized, however, by a quick recovery in that
there were marked differences between them and
the controls 24 hours after injection. In contrast to
both the mercuric chloride and glycerol models, in
the uranyl nitrate model, no significant differences
in BUN values were observed between the low-,
normal-, and high-sodium-diet groups at the end of
24 hours, and a clear separation between the three
groups was achieved only by the second or third
day. This suggests that sodium intake exerts its ef-
fects during the maintenance phase of ARF in the
uranyl nitrate model.
Continued high-sodium diet after the induction of
ARF, as in groups B and F of this study, might be
necessary to confer protection. This may account
for the failure of Flamenbaum et al [27] to observe
protection after 30 hours of 1% sodium chloride in
the myoglobinuric model of ARF, as the rats in this
study were given water after the glycerol injection.
This factor of sodium intake following induction of
ARF might also account, in part, for the somewhat
less complete protection seen in rats drinking so-
dium chloride short-term (group F, Fig. 6), as these
rats were less likely to have achieved a steady-state
with respect to sodium balance.
The mechanism by which the level of sodium in-
take modifies the maintenance phases of these two
nephrotoxic models of ARF, independently of the
activity of the RAS, remains to be clarified. It is not
unreasonable to assume that a state of persistent
diuresis and natriuresis would be likely to minimize
tubular obstruction and increase nephrotoxin clear-
ance, thus decreasing renal accumulation of neph-
rotoxin and attendant necrosis [43] and back-leak of
tubular fluid. Some suggestive evidence for this
postulate has been adduced recently [44], with re-
spect to the mercuric chloride model. Other work-
ers have advanced a similar explanation for the pro-
tective effects of sodium chloride, mannitol, or
prostaglandin administration in both norepineph-
rine and methemoglobin-ferricyanide models [45-
48]. It is possible, however, that there are other, not
yet clarified, mechanisms by which increased so-
dium chloride intake confers protection [49—51].
Whatever the mechanism(s), we wish to emphasize
that in contrast to previous reports in the literature
[1—6, 27], our results demonstrate that long-term
sodium chloride loading is not necessary for pro-
tection, and that substantial protection can be
achieved in both models of ARF by short-term (48
hours) increases in sodium chloride intake. This ob-
servation, taken with the findings of others [20, 45,
47, 48, 52], may have important clinical implica-
tions.
In conclusion, our experiments demonstrate that
the effects of sodium chloride intake on activity of
the RAS are completely independent of its effects
on severity or course of ARF in two nephrotoxic
models (mercuric chloride, uranyl nitrate). Al-
though our results cannot exclude an effect during
the early initiation phase, the effects of sodium
chloride in both models seem to be predominantly
expressed during the maintenance phase, and seem
to consist of attenuating the severity of (in both
models), and hastening the recovery from (in the
mercuric chloride model), acute renal failure. Final-
ly, the protective effects can be achieved with in-
creases in sodium chloride intake of 48 hours' dura-
tion, regardless of increased activity of the RAS.
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